The Lancet Microbe in conversation with

The Lancet Microbe in conversation with

By The Lancet GroupMedicineHealth & Fitness
Download on the App Store

The Lancet Microbe in conversation with episodes

  • Erica Furhmeister on monitoring antimicrobial resistance using faecal metagenomes

    Rebecca Barksby of The Lancet Microbe talks to Dr Erica Furhmeister about monitoring antimicrobial resistance using faecal metagenomes.


    Read the full article:
    https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00137-4/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanmic

    Continue this conversation on social!

    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    20 min
  • Jie Zhou and Anika Singanayagam on their SARS-CoV-2 human challenge study

    Elena Dalla Vecchia of The Lancet Microbe speaks to Dr Jie Zhou and Dr Anika Singanayagam about their SARS-CoV-2 human challenge study.


    Read the full article:

    https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00101-5/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanmic


    Continue this conversation on social!

    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    21 min
  • Hanna Ehrlich on antimalarial drug resistance surveillance

    Elena Dalla Vecchia of The Lancet Microbe speaks to Dr Hanna Ehrlich about antimalarial drug resistance surveillance and her recent cross-sectional study using xenomonitoring in Burkina Faso.


    Read the full article:
    https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00063-0/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanmic

    Continue this conversation on social!

    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    33 min
  • Fabrice Somé sur la surveillance de la résistance aux médicaments antipaludiques (en français)

    Elena Dalla Vecchia du The Lancet Microbe converse avec Dr Fabrice Somé sur la surveillance de la résistance aux médicaments antipaludique et son étude récent qui a utilisé la xenosurveillance en Burkina Faso.


    Pour lire l’article:
    https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00063-0/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanmic


    Continue this conversation on social!

    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    33 min
  • Nichola Calvani on gender equity in science

    Rebecca Barksby of The Lancet Microbe talks to Dr Nichola Calvani about gender equity in science and Herminthology, an online initiative that produces online profiles of women working in parasitology. 

    Continue this conversation on social!

    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    23 min
  • Michael Otto on using probiotics to reduce Staphylococcus aureus

    Rebecca Barksby of The Lancet Microbe talks to Dr Michael Otto and his and his collaborators’ placebo-controlled phase 2 trial that used the probiotic Bacillus subtilis to reduce Staphylococcus aureus in adults who were colonised by the bacteria in the Songkhla region of Thailand.


    Read the full article:
    Probiotic for pathogen-specific Staphylococcus aureus decolonisation in Thailand

    Continue this conversation on social!

    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    21 min
  • David Cameron on phage therapy

    Elena Dalla Vecchia of The Lancet Microbe speaks to Dr David Cameron about phage therapy and his and his colleagues’ recent systematic review and meta-analysis of the efficacy of phage therapy in preclinical models of bacterial infection.


    Read the full article:
    Efficacy of phage therapy in preclinical models of bacterial infection: a systematic review and meta-analysis

    Continue this conversation on social!

    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    10 min
  • Samuel Lipworth on Mycobacterium abscessus

    Jonathan Blott talks to Dr Samuel Lipworth about his and his collaborators' investigation of the epidemiology of Mycobacterium abscessus in England and the risk of person-to-person transmission in health-care settings 

    Continue this conversation on social!

    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    14 min
  • Adrian Martineau on Mycobacterium tuberculosis in Ethiopia

    Rachel Hellier talks to Prof Adrian Martineau about his and his collaborators’ study that identified Mycobacterium tuberculosis complex DNA in CD34-positive peripheral blood mononuclear cells of asymptomatic individuals in Ethiopia, a setting with a high tuberculosis burden.

    Continue this conversation on social!

    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    15 min

About The Lancet Microbe in conversation with

From the publisher's feed

Editors at The Lancet Microbe, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to…

More shows like The Lancet Microbe in conversation with

The Lancet Voice by The Lancet Group

The Lancet Voice

21 Listeners

The Lancet Child & Adolescent Health in conversation with by The Lancet Group

The Lancet Child & Adolescent Health in conversation with

0 Listeners

The Lancet Digital Health in conversation with by The Lancet Group

The Lancet Digital Health in conversation with

0 Listeners

The Lancet Global Health in conversation with by The Lancet Group

The Lancet Global Health in conversation with

2 Listeners

The Lancet Oncology in conversation with by The Lancet Group

The Lancet Oncology in conversation with

1 Listeners

The Lancet Psychiatry in conversation with by The Lancet Group

The Lancet Psychiatry in conversation with

0 Listeners

The Lancet Respiratory Medicine in conversation with by The Lancet Group

The Lancet Respiratory Medicine in conversation with

1 Listeners

The Lancet in conversation with by The Lancet Group

The Lancet in conversation with

0 Listeners

The Lancet Haematology in conversation with by The Lancet Group

The Lancet Haematology in conversation with

0 Listeners

The Lancet Gastroenterology & Hepatology in conversation with by The Lancet Group

The Lancet Gastroenterology & Hepatology in conversation with

0 Listeners

The Lancet Diabetes & Endocrinology in conversation with by The Lancet Group

The Lancet Diabetes & Endocrinology in conversation with

1 Listeners

The Lancet Infectious Diseases in conversation with by The Lancet Group

The Lancet Infectious Diseases in conversation with

0 Listeners

The Lancet Public Health in conversation with by The Lancet Group

The Lancet Public Health in conversation with

1 Listeners

eBioMedicine in conversation with by The Lancet Group

eBioMedicine in conversation with

0 Listeners

In conversation with... by The Lancet Neurology

In conversation with...

0 Listeners

The Lancet Rheumatology in conversation with by The Lancet Group

The Lancet Rheumatology in conversation with

0 Listeners

The Lancet Regional Health Western Pacific in conversation with by The Lancet Group

The Lancet Regional Health Western Pacific in conversation with

0 Listeners

The Lancet Primary Care in conversation with by The Lancet Group

The Lancet Primary Care in conversation with

0 Listeners

The Lancet Regional Health Americas in conversation with by The Lancet Group

The Lancet Regional Health Americas in conversation with

0 Listeners